On March 7, 2024, the board of directors of IIOT-OXYS, Inc., a Nevada corporation (the "Company"), approved and ratified the Company entering into the Debt Exchange Agreement (the "Agreement") dated February 5, 2024 with Cambridge MedSpace LLC, an entity of which the Company's CEO, Clifford L. Emmons shares ownership (the "Lender"). Under the Agreement, the Company agreed to issue to the Lender 57 shares of Series C Preferred Stock in exchange for the forgiveness of $68,825 of principal ($55,000) and accrued and unpaid interest.
Attachments
Original Link
Permalink
Disclaimer
IIOT-OXYS Inc. published this content on
13 March 2024 and is solely responsible for the information contained therein. Distributed by
Public, unedited and unaltered, on
13 March 2024 17:51:07 UTC.
IIOT-OXYS, Inc. is a technology company. The Company is engaged in industrial Internet of things (IIOT), artificial intelligence (AI) and machine learning, edge computing and manufacturing operations. It provides actionable mission-critical insights for the Medical/Pharmaceutical, Manufacturing, Agriculture, Defense, and Structural Health, and other industries. It uses domain-specific AI to solve industrial and environmental challenges. The Company helps its customers maintain machine uptime and increase operational efficiency. Its engineered solutions focus on common sense approaches to machine learning, algorithm development and hardware and software products. The Company designs a system of hardware and software, assembles, installs, monitors data and applies its algorithms to help provide customer insight. It develops algorithms that help its customers create insights from data streams. The Company's wholly owned subsidiaries are OXYS Corporation and HereLab, Inc.
IIOT-OXYS, INC. 
